表紙:エクソソーム診断・治療の世界市場(2022年~2026年)
市場調査レポート
商品コード
1044448

エクソソーム診断・治療の世界市場(2022年~2026年)

Global Exosome Diagnostics and Therapeutics Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
エクソソーム診断・治療の世界市場(2022年~2026年)
出版日: 2021年12月21日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のエクソソーム診断・治療の市場規模は、2022年から2026年の予測期間中に23.49%のCAGRで推移し、4億1,937万米ドルの成長が見込まれています。

同市場の成長を後押しする主な要因には、エクソソーム治療研究の増加や、慢性疾患に対する有効な薬剤の需要の高まりなどが挙げられます。

当レポートでは、世界のエクソソーム診断・治療市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および課題、顧客情勢、エンドユーザー・地域別の分析、さらにベンダー情勢およびベンダー分析などを提供しています。

目次

エグゼクティブサマリー

市場情勢

  • 市場のエコシステム
  • バリューチェーン分析

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:2021年から2026年の予測

ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

エンドユーザー別市場セグメンテーション

  • 市場セグメンテーション
  • エンドユーザー別比較
  • 研究・学術機関:市場規模と予測(2021年~2026年)
  • 製薬・バイオテクノロジー企業:市場規模と予測(2021年~2026年)
  • 商業:市場規模と予測(2021年~2026年)
  • エンドユーザー別市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域:市場規模と予測(2021年~2026年)
  • 主要国
  • 地域情勢別の市場機会
  • 市場促進要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Aethlon Medical Inc.
  • Bio Techne Corp.
  • Evox Therapeutics Ltd.
  • Hologic Inc.
  • JSR Life Sciences LLC
  • Lonza Group Ltd.
  • Nanosomix Inc.
  • NX PharmaGen Inc.
  • QIAGEN NV
  • System Biosciences LLC.

付録

目次
Product Code: IRTNTR71819

Technavio has been monitoring the exosome diagnostics and therapeutics market and it is poised to grow by $ 419.37 mn during 2022-2026, progressing at a CAGR of 23.49% during the forecast period. Our report on the exosome diagnostics and therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing research on exosome therapeutics and increasing demand for effective drugs for chronic diseases. In addition, increasing research on exosome therapeutics is anticipated to boost the growth of the market as well.

The exosome diagnostics and therapeutics market analysis includes the end-user segment and geographic landscape.

Technavio's exosome diagnostics and therapeutics market is segmented as below:

By End-user

  • Research and academic institutes
  • Pharmaceutical and biotechnology companies
  • Commercial

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the increasing focus on early detection of cancer as one of the prime reasons driving the exosome diagnostics and therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on exosome diagnostics and therapeutics market covers the following areas:

  • Exosome diagnostics and therapeutics market sizing
  • Exosome diagnostics and therapeutics market forecast
  • Exosome diagnostics and therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading exosome diagnostics and therapeutics market vendors that include Aethlon Medical Inc., Bio Techne Corp., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, and System Biosciences LLC. Also, the exosome diagnostics and therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by End-user
    • Market segments
    • Comparison by End-user
    • Research and academic institutes - Market size and forecast 2021-2026
    • Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
    • Commercial - Market size and forecast 2021-2026
    • Market opportunity by End-user
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2021-2026
    • Europe - Market size and forecast 2021-2026
    • Asia - Market size and forecast 2021-2026
    • ROW - Market size and forecast 2021-2026
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Aethlon Medical Inc.
    • Bio Techne Corp.
    • Evox Therapeutics Ltd.
    • Hologic Inc.
    • JSR Life Sciences LLC
    • Lonza Group Ltd.
    • Nanosomix Inc.
    • NX PharmaGen Inc.
    • QIAGEN NV
    • System Biosciences LLC.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2021 - 2026 ($ million)
  • 13: Global market: Year-over-year growth 2021 - 2026 (%)
  • 14: Five forces analysis 2021 & 2026
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2021
  • 21: End-user - Market share 2021-2026 (%)
  • 22: Comparison by End-user
  • 23: Research and academic institutes - Market size and forecast 2021-2026 ($ million)
  • 24: Research and academic institutes - Year-over-year growth 2021-2026 (%)
  • 25: Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
  • 26: Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
  • 27: Commercial - Market size and forecast 2021-2026 ($ million)
  • 28: Commercial - Year-over-year growth 2021-2026 (%)
  • 29: Market opportunity by End-user
  • 30: Customer landscape
  • 31: Market share By Geographical Landscape 2021-2026 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2021-2026 ($ million)
  • 34: North America - Year-over-year growth 2021-2026 (%)
  • 35: Europe - Market size and forecast 2021-2026 ($ million)
  • 36: Europe - Year-over-year growth 2021-2026 (%)
  • 37: Asia - Market size and forecast 2021-2026 ($ million)
  • 38: Asia - Year-over-year growth 2021-2026 (%)
  • 39: ROW - Market size and forecast 2021-2026 ($ million)
  • 40: ROW - Year-over-year growth 2021-2026 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Aethlon Medical Inc. - Overview
  • 50: Aethlon Medical Inc. - Business segments
  • 51: Aethlon Medical Inc. - Key offerings
  • 52: Aethlon Medical Inc. - Key customers
  • 53: Aethlon Medical Inc. - Segment focus
  • 54: Bio Techne Corp. - Overview
  • 55: Bio Techne Corp. - Business segments
  • 56: Bio Techne Corp. - Key offerings
  • 57: Bio Techne Corp. - Key customers
  • 58: Bio Techne Corp. - Segment focus
  • 59: Evox Therapeutics Ltd. - Overview
  • 60: Evox Therapeutics Ltd. - Product and service
  • 61: Evox Therapeutics Ltd. - Key offerings
  • 62: Evox Therapeutics Ltd. - Key customers
  • 63: Evox Therapeutics Ltd. - Segment focus
  • 64: Hologic Inc. - Overview
  • 65: Hologic Inc. - Business segments
  • 66: Hologic Inc. - Key offerings
  • 67: Hologic Inc. - Key customers
  • 68: Hologic Inc. - Segment focus
  • 69: JSR Life Sciences LLC - Overview
  • 70: JSR Life Sciences LLC - Product and service
  • 71: JSR Life Sciences LLC - Key offerings
  • 72: JSR Life Sciences LLC - Key customers
  • 73: JSR Life Sciences LLC - Segment focus
  • 74: Lonza Group Ltd. - Overview
  • 75: Lonza Group Ltd. - Business segments
  • 76: Lonza Group Ltd. - Key offerings
  • 77: Lonza Group Ltd. - Key customers
  • 78: Lonza Group Ltd. - Segment focus
  • 79: Nanosomix Inc. - Overview
  • 80: Nanosomix Inc. - Product and service
  • 81: Nanosomix Inc. - Key offerings
  • 82: Nanosomix Inc. - Key customers
  • 83: Nanosomix Inc. - Segment focus
  • 84: NX PharmaGen Inc. - Overview
  • 85: NX PharmaGen Inc. - Product and service
  • 86: NX PharmaGen Inc. - Key offerings
  • 87: NX PharmaGen Inc. - Key customers
  • 88: NX PharmaGen Inc. - Segment focus
  • 89: QIAGEN NV - Overview
  • 90: QIAGEN NV - Business segments
  • 91: QIAGEN NV - Key offerings
  • 92: QIAGEN NV - Key customers
  • 93: QIAGEN NV - Segment focus
  • 94: System Biosciences LLC. - Overview
  • 95: System Biosciences LLC. - Product and service
  • 96: System Biosciences LLC. - Key offerings
  • 97: System Biosciences LLC. - Key customers
  • 98: System Biosciences LLC. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations